• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiol Cases . Impaired myocardial perfusion and myocardial inflammation of acute myopericarditis associated with COVID-19

tetano

Editor, Senior Moderator
J Cardiol Cases


. 2024 Oct 29;31(1):12-16.
doi: 10.1016/j.jccase.2024.09.008. eCollection 2025 Jan. Impaired myocardial perfusion and myocardial inflammation of acute myopericarditis associated with COVID-19

Shiro Miura[SUP] 1 [/SUP], Kisaki Amemiya[SUP] 2 [/SUP], Atsutaka Okizaki[SUP] 3 [/SUP], Osamu Manabe[SUP] 4 [/SUP], Shingo Tsujinaga[SUP] 1 [/SUP], Chihoko Miyazaki[SUP] 5 [/SUP], Yoshihiko Ikeda[SUP] 2 [/SUP], Kinta Hatakeyama[SUP] 2 [/SUP], Shuji Takahashi[SUP] 6 [/SUP], Takehiro Yamashita[SUP] 1 [/SUP]



Affiliations
Abstract

Myocarditis and pericarditis, or myopericarditis, is a rare, albeit life-threatening, cardiac complication of coronavirus disease 2019 (COVID-19). Although most patients recover from myocardial inflammation within weeks of the acute infection, there are concerns about acute and long-term myocardial injury. Coronary microvascular dysfunction and myocardial inflammation in the affected myocardium might be key factors in developing acute COVID-19-associated myopericarditis. In this case report, we describe a 38-year-old woman diagnosed with acute COVID-19-associated myopericarditis who was treated successfully. This case highlights the remarkable recovery in coronary microcirculation and myocardial inflammation assessed using multi-imaging modalities from the acute phase to 3-month follow-up using histopathological assessments.
Learning objective: Acute myopericarditis is one of the serious cardiac complications associated with severe acute respiratory syndrome coronavirus 2 infection, although an accurate diagnosis might be challenging. We emphasize a novel combination of magnetic resonance imaging and positron emission tomography focusing on serial changes in coronary microcirculation and myocardial inflammation from acute to recovery phases. Our findings may elucidate the pathophysiology of this entity at the micro and macro levels.

Keywords: Coronavirus disease 2019; Inflammation; Magnetic resonance imaging; Microcirculation; Pathology; Positron emission tomography.

 
Back
Top Bottom